JP2014516033A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516033A5
JP2014516033A5 JP2014511450A JP2014511450A JP2014516033A5 JP 2014516033 A5 JP2014516033 A5 JP 2014516033A5 JP 2014511450 A JP2014511450 A JP 2014511450A JP 2014511450 A JP2014511450 A JP 2014511450A JP 2014516033 A5 JP2014516033 A5 JP 2014516033A5
Authority
JP
Japan
Prior art keywords
halo
independently hydrogen
independently
medicament according
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516033A (ja
JP5833745B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/037895 external-priority patent/WO2012158672A2/en
Publication of JP2014516033A publication Critical patent/JP2014516033A/ja
Publication of JP2014516033A5 publication Critical patent/JP2014516033A5/ja
Application granted granted Critical
Publication of JP5833745B2 publication Critical patent/JP5833745B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511450A 2011-05-16 2012-05-15 粘膜炎の治療に使用するための化合物 Expired - Fee Related JP5833745B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161486455P 2011-05-16 2011-05-16
US61/486,455 2011-05-16
PCT/US2012/037895 WO2012158672A2 (en) 2011-05-16 2012-05-15 Compounds for use in treatment of mucositis

Publications (3)

Publication Number Publication Date
JP2014516033A JP2014516033A (ja) 2014-07-07
JP2014516033A5 true JP2014516033A5 (cg-RX-API-DMAC7.html) 2015-07-02
JP5833745B2 JP5833745B2 (ja) 2015-12-16

Family

ID=47175383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511450A Expired - Fee Related JP5833745B2 (ja) 2011-05-16 2012-05-15 粘膜炎の治療に使用するための化合物

Country Status (14)

Country Link
US (6) US8802683B2 (cg-RX-API-DMAC7.html)
EP (1) EP2709619B1 (cg-RX-API-DMAC7.html)
JP (1) JP5833745B2 (cg-RX-API-DMAC7.html)
KR (1) KR102012164B1 (cg-RX-API-DMAC7.html)
CN (1) CN103957710B (cg-RX-API-DMAC7.html)
AU (1) AU2012255935B2 (cg-RX-API-DMAC7.html)
CA (1) CA2836099C (cg-RX-API-DMAC7.html)
DK (1) DK2709619T3 (cg-RX-API-DMAC7.html)
IL (1) IL229381B (cg-RX-API-DMAC7.html)
MX (1) MX2013013330A (cg-RX-API-DMAC7.html)
RU (1) RU2606128C2 (cg-RX-API-DMAC7.html)
TW (1) TWI520951B (cg-RX-API-DMAC7.html)
WO (1) WO2012158672A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201308541B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
RU2606128C2 (ru) * 2011-05-16 2017-01-10 Селлсьютикс Корпорейшн Соединения для применения в лечении мукозита
EP2934563B1 (en) * 2012-12-18 2020-07-08 Jawaharlal Nehru Centre for Advanced Scientific Research Antimicrobial compounds, their synthesis and applications thereof
JP6474736B2 (ja) * 2013-02-15 2019-02-27 テヒーニィシエ ウニヴェルジテート ベルリン アルビシジン誘導体、その使用および合成
MX364611B (es) * 2013-03-15 2019-05-02 Genzyme Corp Poliamidas con funcionalidad amina.
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および/または治療のための宿主防御タンパク質(hdp)模倣薬
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
AU2019223182B2 (en) 2018-02-26 2021-08-19 Gilead Sciences, Inc. Substituted pyrrolizine compounds as HBV replication inhibitors
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
US20250064890A1 (en) 2021-08-30 2025-02-27 Unichem Laboratories Limited Protein compositions for the treatment of inflammatory diseases
CN114890982A (zh) * 2022-05-16 2022-08-12 内蒙古大学 一种季铵盐修饰的二苯并噻吩亚砜衍生物的制备方法
CN117402075A (zh) * 2023-10-17 2024-01-16 厦门大学深圳研究院 一种具有特异性抗肿瘤活性的可见光响应的人工h+/ci-离子通道的制备

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496179A (en) 1967-10-11 1970-02-17 Pfizer & Co C 2-amino-3,4-dihydroquinazolines
CA2128612C (en) 1992-01-23 1999-06-15 Mamoru Tomita Antimicrobial agents and method for treating products therewith
US6025326A (en) 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
JP3090125B2 (ja) 1997-08-26 2000-09-18 千寿製薬株式会社 ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
JP2003523927A (ja) 1998-08-20 2003-08-12 ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル ジカチオンジベンゾフランおよびジベンゾチオフェン化合物並びにその使用法
US20040152664A1 (en) 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US6440964B1 (en) 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
JP2001261674A (ja) 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
FR2813080B1 (fr) 2000-08-17 2002-11-29 Stago Diagnostica Peptides anti-heparine
JP2004525865A (ja) 2000-11-08 2004-08-26 バイオ−コンセプト・ラボラトリーズ 過酸化物源およびカチオン性ポリマー防腐剤を含有する改良した眼科用およびコンタクトレンズ用溶液
BR0206734A (pt) * 2001-01-18 2004-03-02 Genzyme Corp Polìmeros de ioneno e seu uso como agentes antimicrobianos
CA2789997A1 (en) 2001-03-08 2002-12-19 William F. Degrado Facially amphiphilic polymers an anti-infective agents
US7629317B2 (en) 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
AR034372A1 (es) 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002341566A1 (en) * 2001-08-16 2003-04-01 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
WO2003100701A1 (en) 2002-05-28 2003-12-04 The Trustees Of The University Of Pennsylvania Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
US8234074B2 (en) 2002-06-13 2012-07-31 The Trustees Of The University Of Pennsylvania Methods, systems, and computer program products for simulating biomembrances using coarse grain models
AU2003291087A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Ionene oligomers and polymers
EP2471525A3 (en) * 2003-03-17 2012-12-12 The Trustees Of The University Of Pennsylvania Facially amphiphllic polymers and oligomers and uses thereof
AU2003249114A1 (en) 2003-03-20 2004-10-11 Shiseido International France Cosmetic composition
US20040202687A1 (en) 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US20050065091A1 (en) 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
TWI388280B (zh) 2004-01-23 2013-03-11 Univ Pennsylvania 面上兩性之聚芳基和聚芳炔基聚合物與寡聚物及其用途
CN102653515A (zh) 2004-06-15 2012-09-05 宝利麦迪克斯股份有限公司 聚阳离子化合物及其用途
WO2006132647A2 (en) 2004-07-23 2006-12-14 The Trustees Of The University Of Pennsylvania Antimicrobial copolymers and uses thereof
CA2599205A1 (en) 2005-02-25 2006-09-08 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
EP1704860B1 (en) * 2005-03-24 2010-10-27 Rottapharm S.P.A. Benzamidine derivatives for treatment and prevention of mucositis
AU2006244080C1 (en) * 2005-05-10 2012-02-02 The University Of Chicago Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
JP2008137978A (ja) 2006-12-05 2008-06-19 Canon Inc カルバゾール誘導体及びこれを用いた有機発光素子
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
CN102164892A (zh) * 2008-07-28 2011-08-24 波利梅伊公司 抗疟疾化合物
US8278309B2 (en) * 2008-10-27 2012-10-02 Polymedix, Inc. Synthetic mimetics of host defense and uses thereof
BRPI0922947A2 (pt) * 2008-12-10 2015-08-25 Polymedix Inc Métodos para inibir o crescimento de uma espécie de mycobacterium, e para tratar um animal tendo uma infecção de mycobacterium, e, composto.
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
JP2013516470A (ja) * 2010-01-07 2013-05-13 ポリメディックス・インコーポレーテッド 抗ヘパリン化合物
TW201208677A (en) * 2010-08-21 2012-03-01 Polymedix Inc Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
RU2606128C2 (ru) * 2011-05-16 2017-01-10 Селлсьютикс Корпорейшн Соединения для применения в лечении мукозита
US9469616B2 (en) * 2011-12-13 2016-10-18 Cellceutix Corporation Cyclic compounds and methods of making and using the same
AU2013209622A1 (en) * 2012-01-18 2014-09-11 Cellceutix Corporation Compounds and methods for treating Candidiasis and Aspergillus infections
WO2014093225A2 (en) * 2012-12-10 2014-06-19 Cellceutix Corporation Polycyclic compounds and methods of making and using the same
WO2014093231A2 (en) * 2012-12-10 2014-06-19 Cellceutix Corporation Hybrid compounds and methods of making and using the same
CA2912728C (en) * 2013-05-28 2021-04-13 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および/または治療のための宿主防御タンパク質(hdp)模倣薬

Similar Documents

Publication Publication Date Title
JP2014516033A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2006524660A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
JP2014508811A5 (cg-RX-API-DMAC7.html)
JP2013542261A5 (cg-RX-API-DMAC7.html)
JP2013512277A5 (cg-RX-API-DMAC7.html)
JP2010525056A5 (cg-RX-API-DMAC7.html)
JP2013531031A5 (cg-RX-API-DMAC7.html)
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2013534248A5 (cg-RX-API-DMAC7.html)
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
JP2013537203A5 (cg-RX-API-DMAC7.html)
JP2016503793A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2015501783A5 (cg-RX-API-DMAC7.html)
JP2016509589A5 (cg-RX-API-DMAC7.html)
RU2015117251A (ru) Новые соединения
JP2013518107A5 (cg-RX-API-DMAC7.html)
JP2007302689A5 (cg-RX-API-DMAC7.html)
IL221744A (en) Use of a combination of compounds to prepare a drug to treat Parkinson's disease
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2009507896A5 (cg-RX-API-DMAC7.html)
JP2013532687A5 (cg-RX-API-DMAC7.html)